BioSpace News Archive

The report developed by Transparency Market Research on the global capnography equipment market expects to reach an overall market cap of US$615.6 mn by the fall of 2020.

Neuropathic pain is defined as pain that occurs due to damage to nerve endings, usually on the surface of the body.

Curated Menu of Off-the-Shelf RNAscope Probes Provide Molecularly-Guided Region of Interest Selection for Use with the New NGS-Enabled Cancer Transcriptome Atlas

Reported net sales of $491 million, down 51.4% vs. prior year, impacted by COVID-19. Organic sales declined 49.9% versus prior year

Conformal Medical, Inc., a medical device company focused on reducing stroke in patients with atrial fibrillation, announced it has secured $85 million in Series C financing.

Amneal Pharmaceuticals, Inc. announced its results for the second quarter ended June 30, 2020.

Aviptadil is now shown as the first COVID therapeutic to block replication of the SARS-CoV-2 virus in human lung cells and monocytes, while also preventing synthesis of cytokines in the lung

Curated Menu of Off-the-Shelf RNAscope Probes Provide Seamless Molecularly-Guided Region of Interest Selection for Use With the New NGS-Enabled Cancer Transcriptome Atlas

Baudax Bio, Inc., a pharmaceutical company focused on therapeutics for acute care settings, announced that the Centers for Medicare and Medicaid Services established a new permanent J-code for ANJESO injection facilitating reimbursement in the hospital outpatient, ambulatory surgery center and physician office settings of care.

Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL), an SEC fully-reporting, growth-oriented manufacturing and marketing company focused on employing FDA-approved Metered Dose Inhaler (MDI) technology to deliver aerosolized cannabinoids, such as CBD, CBG, and CBN, announces its relationship with Ezzey Digital Marketing Agency to launch its new proprietary aerosol inhaler and lifestyle brand to be called nhāler. RTSL digital infrastructure built